Fig. 4From: Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessmentDuration of hospitalization (A), mortality (B)Back to article page